Stradley Ronon Strengthens Litigation Team with New Partners

Stradley Ronon enhances its litigation and investigations capabilities by appointing Jordann Conaboy and Benjamin McCoy as partners, bringing extensive experience in health care, managed care, and pharmaceutical disputes.

June 3, 2025
Stradley Ronon Strengthens Litigation Team with New Partners

Stradley Ronon has announced the appointment of Jordann Conaboy and Benjamin McCoy as partners in its Philadelphia office, significantly bolstering the firm's litigation and investigations team. Both attorneys bring a wealth of experience from their previous roles at Fox Rothschild, with Conaboy also serving as an assistant U.S. attorney in the District of New Jersey. Their expertise in complex litigation, particularly in health care, managed care, and pharmaceutical disputes, positions Stradley Ronon to better navigate the intricate regulatory and legal challenges facing clients in these sectors.

Jeff Grossman, co-chair of the firm's litigation practice, highlighted the strategic importance of these appointments. Conaboy and McCoy's combined experience in handling fraud claims, RICO cases, and government investigations enhances the firm's ability to represent clients effectively. Their track record includes securing judgments and settlements worth hundreds of millions of dollars, demonstrating their capability to manage high-stakes litigation.

Conaboy's background as a prosecutor, where he tackled significant health care fraud and opioid-related cases, complements McCoy's experience in defending health insurers against large-scale fraud operations. This synergy is expected to provide Stradley Ronon's clients with a comprehensive defense strategy against affirmative litigation and regulatory challenges. The addition of Conaboy and McCoy is part of the firm's broader growth strategy in the litigation and health care sectors, following the recent integration of a five-lawyer insurance/reinsurance litigation team in New York and Washington, D.C.

The appointments underscore the increasing complexity of legal and regulatory issues in the health care and pharmaceutical industries. With their deep expertise, Conaboy and McCoy are poised to play a pivotal role in addressing these challenges, offering clients robust representation in disputes that have significant financial and operational implications.